The U.S. government is working to bridge the gap in funding needed to continue the encouraging CAPRISA vaginal microbicide research trial with a combination of funding from USG, the South African government and possibly private donors. Sources say this is in response to a New York Times piece that ran on September 3 entitled “HIV […]